Evidence map›Paper›PMID 32626284›Full record

ArticleEFSA journal. European Food Safety Authority2019

Safety of betaine as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA Panel on Nutrition, Novel Foods and Food Allergens (EFSA NDA Panel), Dominique Turck, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch-Ernst, John Kearney, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska and 19 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Methyl Group Metabolism in Differentiation, Aging, and Cancer.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Safety of betaine as a novel food pursuant to Regulation (EU) 2015/2283.EFSA journal. European Food Safety Authority · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

EFSA Panel on Nutrition, Novel Foods and Food Allergens (EFSA NDA Panel)
Dominique Turck
Jacqueline Castenmiller
Stefaan De Henauw
Karen Ildico Hirsch-Ernst
John Kearney
Alexandre Maciuk
Inge Mangelsdorf
Harry J McArdle
Androniki Naska
Carmen Pelaez
Kristina Pentieva
Alfonso Siani
Frank Thies
Sophia Tsabouri
Marco Vinceti
Francesco Cubadda
Karl Heinz Engel
Thomas Frenzel
Marina Heinonen
Rosangela Marchelli
Monika Neuhäuser-Berthold
Annette Pöting
Morten Poulsen
Yolanda Sanz
Josef Rudolf Schlatter
Henk van Loveren
Emanuela Turla
Helle Katrine Knutsen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2017, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) concluded that betaine as a novel food (NF) is safe to be used at a maximum intake level of 6 mg/kg body weight per day in addition to the intake from the background diet. Following the present request from the European Commission, the EFSA NDA Panel was asked to deliver a scientific opinion on betaine by carrying out the assessment for the revised uses and use levels of betaine as proposed by the applicant. Thus, EFSA performed an intake assessment based on individual data from the EFSA Comprehensive European Food Consumption Database and the new proposed uses of the NF for the general population. The resulting ranges for the mean and high-level estimated intakes of betaine for the general population do not exceed the safe level of intake previously established. The Panel concludes that the NF, betaine, is safe under the new proposed conditions of use.

Indexed as

betaineintake assessmentnovel food

Identifiers

PMID32626284
PMCPMC7009179

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.